Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:1363-1369
Published online before print March 2, 2009, doi: 10.1161/CIRCULATIONAHA.108.816082
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: March 17, 2009, Volume 119, Number 10
Right arrow All Versions of this Article:
119/10/1363    most recent
CIRCULATIONAHA.108.816082v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Go, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Go, A. S.
Related Collections
Right arrow Acute Cerebral Infarction
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Embolic stroke
Right arrow Epidemiology
Right arrowRelated Article

(Circulation. 2009;119:1363-1369.)
© 2009 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation

The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Alan S. Go, MD; Margaret C. Fang, MD, MPH; Natalia Udaltsova, PhD; Yuchiao Chang, PhD; Niela K. Pomernacki, RD; Leila Borowsky, MPH; Daniel E. Singer, MD, for the ATRIA Study Investigators

From the Division of Research, Kaiser Permanente of Northern California, Oakland (A.S.G., N.U., N.K.P.); Departments of Epidemiology, Biostatistics, and Medicine, University of California at San Francisco (A.S.G., M.C.F.); and Clinical Epidemiology Unit, General Medicine Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston (Y.C., L.B., D.E.S.).

Correspondence to Alan S. Go, MD, Division of Research, Kaiser Permanente of Northern California, 2000 Broadway St, 3rd Floor, Oakland, CA 94612. E-mail Alan.S.Go{at}kp.org

Received September 16, 2008; accepted December 15, 2008.

Background— Atrial fibrillation (AF) substantially increases the risk of ischemic stroke, but this risk varies among individual patients with AF. Existing risk stratification schemes have limited predictive ability. Chronic kidney disease is a major cardiovascular risk factor, but whether it independently increases the risk for ischemic stroke in persons with AF is unknown.

Methods and Results— We examined how chronic kidney disease (reduced glomerular filtration rate or proteinuria) affects the risk of thromboembolism off anticoagulation in patients with AF. We estimated glomerular filtration rate using the Modification of Diet in Renal Disease equation and proteinuria from urine dipstick results found in laboratory databases. Patient characteristics, warfarin use, and thromboembolic events were ascertained from clinical databases, with validation of thromboembolism by chart review. During 33 165 person-years off anticoagulation among 10 908 patients with AF, we observed 676 incident thromboembolic events. After adjustment for known risk factors for stroke and other confounders, proteinuria increased the risk of thromboembolism by 54% (relative risk, 1.54; 95% CI, 1.29 to 1.85), and there was a graded, increased risk of stroke associated with a progressively lower level of estimated glomerular filtration rate compared with a rate ≥60 mL · min–1 · 1.73 m–2: relative risk of 1.16 (95% CI, 0.95 to 1.40) for estimated glomerular filtration rate of 45 to 59 mL · min–1 · 1.73 m–2 and 1.39 (95% CI, 1.13 to 1.71) for estimated glomerular filtration rate <45 mL · min–1 · 1.73 m–2 (P=0.0082 for trend).

Conclusions— Chronic kidney disease increases the risk of thromboembolism in AF independently of other risk factors. Knowing the level of kidney function and the presence of proteinuria may improve risk stratification for decision making about the use of antithrombotic therapy for stroke prevention in AF.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 119: 1353-1354. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
V. Barrios, C. Escobar, and R. Echarri
Letter by Barrios et al Regarding Article, "Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study"
Circulation, November 3, 2009; 120(18): e153 - e153.
[Full Text] [PDF]


Home page
CirculationHome page
A. S. Go, N. Udaltsova, N. K. Pomernacki, M. C. Fang, Y. Chang, L. Borowsky, and D. E. Singer
Response to Letter Regarding Article, "Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study"
Circulation, November 3, 2009; 120(18): e154 - e154.
[Full Text] [PDF]


Home page
ChestHome page
M. M. Sood, P. Komenda, A. R. Sood, C. Rigatto, and J. Bueti
The Intersection of Risk and Benefit: Is Warfarin Anticoagulation Suitable for Atrial Fibrillation in Patients on Hemodialysis?
Chest, October 1, 2009; 136(4): 1128 - 1133.
[Abstract] [Full Text] [PDF]